Eisai to file new Aricept formulation, wants out of Pfizer pact Eisai is looking to file a new formulation of Aricept this summer and is confident about terminating its collaboration with Pfizer, the Japanese drugmaker’s marketing partner for the Alzheimer's disease blockbuster
FDA concerned about King/Acura's painkiller Acurox King Pharmaceuticals and Acura are facing a deal in getting their painkiller Acurox onto the market after regulators in the USA issued a letter expressing concerns about the drug's abuse-deterrent properties
Roche/Genentech to seek a new approval for Lucentis Roche’s Genentech unit has presented promising data which it hopes will result in an approval for a second indication of the sight drug Lucentis
FDA demands boxed warnings on Chantix and Zyban Regulators in the USA have told Pfizer and GlaxoSmithKline to include a boxed warning on their smoking cessation products, Chantix and Zyban, about the risk of "serious mental health events”
